These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30924446)

  • 1. Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions.
    Tchero H; Herlin C; Bekara F; Fluieraru S; Teot L
    Indian J Dermatol Venereol Leprol; 2019; 85(3):248-257. PubMed ID: 30924446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for hidradenitis suppurativa.
    Ingram JR; Woo PN; Chua SL; Ormerod AD; Desai N; Kai AC; Hood K; Burton T; Kerdel F; Garner SE; Piguet V
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010081. PubMed ID: 26443004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa: Review of the Pathogenesis and Treatment.
    Kurayev A; Ashkar H; Saraiya A; Gottlieb AB
    J Drugs Dermatol; 2016 Aug; 15(8):1017-22. PubMed ID: 27538005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa: Current and emerging treatments.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1061-1082. PubMed ID: 31604100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hidradenitis suppurativa - symptoms, diagnostics, and therapy].
    Arenbergerová M; Dahmen RA; Arenberger P
    Cas Lek Cesk; 2017; 156(3):127-132. PubMed ID: 28722455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-surgical treatments for hidradenitis suppurativa: A systematic review.
    Robert E; Bodin F; Paul C; Konstantinou MP; Gall Y; Grolleau JL; Laloze J; Chaput B
    Ann Chir Plast Esthet; 2017 Aug; 62(4):274-294. PubMed ID: 28457725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa.
    Danby FW; Margesson LJ
    Dermatol Clin; 2010 Oct; 28(4):779-93. PubMed ID: 20883920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.
    Alikhan A; Sayed C; Alavi A; Alhusayen R; Brassard A; Burkhart C; Crowell K; Eisen DB; Gottlieb AB; Hamzavi I; Hazen PG; Jaleel T; Kimball AB; Kirby J; Lowes MA; Micheletti R; Miller A; Naik HB; Orgill D; Poulin Y
    J Am Acad Dermatol; 2019 Jul; 81(1):76-90. PubMed ID: 30872156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
    Theut Riis P; Thorlacius LR; Jemec GB
    Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging medical treatments for hidradenitis suppurativa.
    Lyons AB; Shabeeb N; Nicholson CL; Braunberger TL; Peacock A; Hamzavi IH
    J Am Acad Dermatol; 2020 Aug; 83(2):554-562. PubMed ID: 32289386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidradenitis suppurativa: a comprehensive review.
    Alikhan A; Lynch PJ; Eisen DB
    J Am Acad Dermatol; 2009 Apr; 60(4):539-61; quiz 562-3. PubMed ID: 19293006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition, diagnosis, and treatment of hidradenitis suppurativa.
    Duran C; Baumeister A
    JAAPA; 2019 Oct; 32(10):36-42. PubMed ID: 31567740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1015-26. PubMed ID: 27531618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis Suppurativa and Wound Management.
    Dini V; Oranges T; Rotella L; Romanelli M
    Int J Low Extrem Wounds; 2015 Sep; 14(3):236-44. PubMed ID: 26248827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medical and laser management of hidradenitis suppurativa.
    Hughes R; Kelly G; Sweeny C; Lally A; Kirby B
    Am J Clin Dermatol; 2015 Apr; 16(2):111-23. PubMed ID: 25708371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.